Mark Brooke hopes the program will signal a new era of hope for lung cancer patients. (ABC News: Lucas Hill)The screening program will offer a bulk-billed low-dose CT scan for the 930,000 people ...

Like other forms of lung cancer, adenocarcinoma is usually diagnosed at an advanced stage. "If there's a 1cm (0.4in) tumour hidden somewhere in your lungs, you won't notice it," says Wicki.

IPF is a chronic disease that causes lung tissue to thicken and stiffen, leading to breathing difficulties. During a 12-week study of rentosertib, which enrolled 71 patients in China, Insilico ...

Get Instant Summarized Text (Gist) A lipid nanoparticle system was developed to deliver DNase I and Sivelestat directly to lung neutrophils in a COVID-19 mouse model.

'How to Train Your Dragon' meal at Burger King. Dragon Flame-Grilled Whopper: Features a ¼ pound of flame-grilled beef served on a red-and-orange-marbled bun colored with natural spices and ...

In doing so, it has also identified a way to reverse that damage and restore lung function. We already know that exposure to air pollution is bad for us , and it’s particularly damaging for our ...

Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments. Skip to main content. Your source for the latest research news.

Sanofi’s shares fell following mixed results of its experimental drug for a deadly lung condition. Itepekimab, a medicine that is being jointly developed by Sanofi and Regeneron, is being tested ...

Elon Musk said SpaceX will decommission its Dragon spacecraft immediately amid his feud with Trump. The announcement came after Trump said canceling Musk's government contracts would save money ...

The Inferno Dragon evolution has significantly impacted Clash Royale, becoming a top tank killer due to its beam momentum and escalating damage. Several decks maximize its potential, including Ram ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.